Biopharmaceutical company Alkermes plc (ALKS) on Thursday initiated earnings and revenue for fiscal 2019. The company now projects earnings in a range of $0.87 to $1.06 per share and adjusted earnings in the range of $0.26 to $0.45 per share.
from RTT - Earnings http://bit.ly/2TOtz8x
via IFTTT
No comments:
Post a Comment